SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-033452
Filing Date
2006-05-10
Accepted
2006-05-10 17:30:30
Documents
4
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-9401_110q.htm 10-Q 604263
2 EX-31 a06-9401_1ex31d1.htm EX-31.1 10502
3 EX-31 a06-9401_1ex31d2.htm EX-31.2 10235
4 EX-32 a06-9401_1ex32d1.htm EX-32.1 7630
  Complete submission text file 0001104659-06-033452.txt   634118
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 06827582
SIC: 2835 In Vitro & In Vivo Diagnostic Substances